ThyCa News

Survey Seeks Your Input on RAI and the Salivary Glands

01/2011

If you have received radioactive iodine (I-131) to treat your thyroid cancer, you're invited to complete the online Salivary Gland Survey.

Or, if you are a guardian of a minor or another individual who received an I-131 therapy (RAI), please complete this survey for that individual.

ThyCa: Thyroid Cancer Survivors' Association, Inc. is helping ThyCa Medical Advisors Douglas Van Nostrand, M.D., and Brian McIver, M.B., Ph.D., as well as the other researchers who are conducting this study.

The purpose of this survey is to identify whether or not you had several side effects from your last I-131therapy and to help identify factors that may have increased, decreased, or prevented these side effects.

Please complete this online survey form. Your information will remain anonymous and confidential.

This is an opportunity for us to help others and ourselves. Together, we are helping to improve knowledge and care for people with thyroid cancer.


News Archive